Navigation Links
Medicare modernization act did not change chemotherapy as feared
Date:10/7/2007

DURHAM, N.C. -- Cancer patients receiving chemotherapy have not noticed a restriction in their access to treatment following the enactment of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), despite the act's significant reduction in government reimbursement to oncologists, according to a new study led by researchers in the Duke Clinical Research Institute (DCRI).

Critics of the MMA often said that it would reduce patients access to chemotherapy services, because doctors would receive 30 to 40 percent less reimbursement from the government for administering treatment, said Kevin Schulman, M.D., director of the DCRIs Center for Clinical and Genetic Economics, and senior investigator on the study. Our study showed that patients actually do not perceive barriers to their access to chemotherapy and perceptions about access are really the same among patients who received treatment before the legislation went into effect, and those who received it afterwards.

The team's findings will be published in the November 15, 2007 print edition of the journal Cancer, but also will appear earlier in the journals October 8, 2007 online edition. The study was funded by a grant from the National Patient Advocate Foundations Global Access Project, which brings together 42 national healthcare stakeholder groups -- such as pharmaceutical companies and advocacy groups -- to fund health research projects. The Project has focused on examining the MMAs consequences for patients, providers and healthcare systems.

The Duke researchers examined the results of 1421 surveys completed via the internet by 684 patients who had received chemotherapy prior to the enactment of the MMA and 737 patients who were treated after it went into effect. Respondents answered questions related to issues including the amount of time they waited to start chemotherapy after their initial cancer diagnosis, and how far they had to travel to get their trea
'/>"/>

Contact: Lauren Shaftel Williams
lauren.shaftel@duke.edu
919-684-4966
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. House heads for Medicare drug vote
3. New Medicare Plan - Mixed Reaction among Pharmacists.
4. Medicare Data would help in Drug Validation
5. Medicare Queries Expected To Increase Over Time
6. Medicare to cover services provided by rural health care personnels.
7. Cancer test expenses taken up by Medicare
8. Nurse Practitioners Are Not Recognized By Medicare
9. Medicare Drug Plan Is Not Working in The US
10. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
11. Rising Medicare costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... City, OK and Seattle, WA (PRWEB) May 04, 2015 ... announced the formation of a collaboration to facilitate development ... number of ophthalmic disorders that lead to blindness, including ... to the MiDROPS™ formulation platform developed by EyeCRO, which ... the eye via a topical eyedrop. , Under ...
(Date:5/4/2015)... NC (PRWEB) May 04, 2015 CCL, ... to offer this unique program to other leadership development ... valuable ties between CCL and successful practitioners, expanding our ... around the globe,” said John R. Ryan, CCL President ... joins the CCL Partner Network , it will ...
(Date:5/4/2015)... 2015 New West Medicare is excited ... LLC to manage outpatient advanced imaging services for its ... ensure its members are provided the right test at ... closely with New West Medicare’s physicians and hospitals, Care ... of advanced imaging and provide an objective basis for ...
(Date:5/4/2015)... Pa. (PRWEB) May 04, 2015 Sylvia Hawthorn-Deppen ... the hopes that it would remind others in similar situations ... A Recovery from Chronic Pain and Discovery of New Energy” ... with a new audience via a renewed press campaign. , ... with debilitating pain ,” Hawthorn-Deppen says. “As an adolescent ...
(Date:5/4/2015)... 04, 2015 Fast on the heels ... Trace Amounts, and Allison Folmar, JD, join over 150 ... internationally. , On Sunday, May 24, the conference presents ... possible?" Are you interested in Ryan Hinds' recovery story? ... our war against autism was written by Marcia ...
Breaking Medicine News(10 mins):Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4
... Nov. 19 Smart Balance, Inc. (Nasdaq: SMBL ) ... to drive growth and performance at the Citi Investment Research ... strategy to build market share in the company,s core spreads ... of food and beverages to support healthy living under the ...
... JACKSONVILLE, Fla., Nov. 19 Improving the quality of ... will be addressed by Dr. Krysti DeZonia, co-founder of ... of the International Association for Life Quality (IALQ), at ... Fl. , The WCD Expo is dedicated ...
... Hopkins and their colleagues have developed sugar-coated polymer strands ... allergy and asthma attacks. Their advance is a significant ... conditions in a new way. For more than ... M.D., director of the Division of Allergy and Clinical ...
... Heart disease, stroke more likely for organ recipients with ... (HealthDay News) -- Kidney transplant patients with sleep apnea ... disease and stroke, Hungarian researchers say. , The study ... had moderate to severe sleep apnea, a rate similar ...
... analysis finds some areas with 1 in 10 adults ... While rates of obesity are climbing across America, they ... Southeast, the U.S. Centers for Disease Control and Prevention ... diabetes "are basically the two conditions of greatest concern ...
... Lisa Maas, executive director of Californians Allied for ... to an Associated Press/Stanford University poll released today which ... personal injury lawyers to sue health care providers. ... community clinics, local governments, dentists and other groups supporting ...
Cached Medicine News:Health News:Smart Balance, Inc. CEO Presents at Citigroup Small and Midcap Conference 2Health News:Smart Balance, Inc. CEO Presents at Citigroup Small and Midcap Conference 3Health News:Smart Balance, Inc. CEO Presents at Citigroup Small and Midcap Conference 4Health News:Dr. Krysti DeZonia to Speak at World Congress on Disabilities 2Health News:Sweet -- sugared polymer a new weapon against allergies and asthma 2Health News:Sweet -- sugared polymer a new weapon against allergies and asthma 3Health News:Kidney Transplant, Sleep Disorder May Add Up to Trouble 2Health News:Appalachia, Southeast Hit Hardest by Obesity and Diabetes 2Health News:Appalachia, Southeast Hit Hardest by Obesity and Diabetes 3Health News:National Poll Confirms Americans Support Curbs on Malpractice Lawsuits 2
(Date:5/4/2015)... Unchained Labs, a refreshingly new biologic tools ... conference and launches the UNit — the first and ... Essential Protein Engineering Summit takes place in ... UNit lets drug discovery researchers look at more protein ... 7 applications, 144 sample a day throughput and 9 microliter sample ...
(Date:5/4/2015)... May 4, 2015 Intarcia Therapeutics, ... Michael Williams into the newly created role ... a senior pharmaceutical executive with world-class experience – ... and distinguished service at industry leaders such as ... a broad range of therapeutic areas, including: cardiovascular, ...
(Date:5/4/2015)... N.J. , May 4, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... multiple countries worldwide, will report Q1 2015 financial ... 11, 2015.  CytoSorbents, management will ... that will recount both operational and financial progress ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3
... Inhibitex, Inc. (Nasdaq: INHX ) today announced that ... its common stock, at a purchase price of $4.10 per ... proceeds to Inhibitex from the sale of the shares, after ... to be approximately $44 million.  Inhibitex has granted the underwriters ...
... Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc. (OTCQB/OTCBB: ... Company,s therapeutic and preventative HIV vaccines at the 2011 World ... in Washington DC on Thursday, April 14.  Dr. Robinson,s invited ... cover the topic of recombinant viruses as vaccines. The talk ...
Cached Medicine Technology:Inhibitex Prices $47 Million Public Offering 2Inhibitex Prices $47 Million Public Offering 3GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 2GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: